.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Citi
Merck
Medtronic
Cipla
Harvard Business School
Argus Health
Boehringer Ingelheim
Cantor Fitzgerald
Baxter

Generated: June 28, 2017

DrugPatentWatch Database Preview

EPROSARTAN MESYLATE Drug Profile

« Back to Dashboard

Which patents cover Eprosartan Mesylate, and when can generic versions of Eprosartan Mesylate launch?

Eprosartan Mesylate is a drug marketed by Mylan Pharms Inc and is included in one NDA.

The generic ingredient in EPROSARTAN MESYLATE is eprosartan mesylate. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eprosartan mesylate profile page.

Summary for Tradename: EPROSARTAN MESYLATE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list42
Clinical Trials: see list515
Patent Applications: see list768
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EPROSARTAN MESYLATE at DailyMed

Pharmacology for Tradename: EPROSARTAN MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
EPROSARTAN MESYLATE
eprosartan mesylate
TABLET;ORAL202012-001Nov 16, 2011ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
EPROSARTAN MESYLATE
eprosartan mesylate
TABLET;ORAL202012-002Nov 16, 2011ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Mallinckrodt
Farmers Insurance
Express Scripts
McKinsey
Argus Health
Boehringer Ingelheim
US Department of Justice
Deloitte
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot